Drugs / CPSI-2364
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00950105 | Jul → Oct 2009 | Crohn disease | Ferring Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CPSI-2364 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00950105 ↗ |
| Route | Oral | “Single, oral dose of CPSI-2364 or placebo” NCT00950105 ↗ |